FMC Corp. has built a platform to serve the fast-growing biological crop protection market through two strategic transactions.
FMC Corp. has built a platform to serve the fast-growing biological crop protection market through two strategic transactions. FMC has signed an exclusive and global collaboration agreement with Chr. Hansen, a biosciences company specializing in cultures, enzymes, and fermentation, to develop and commercialize biological crop protection products. FMC also announced the acquisition of the Center for Agricultural and Environmental Biosolutions (CAEB), a division of North Carolina-based RTI International, specializing in sustainable agriculture research. With these two transactions, FMC Agricultural Solutions has created an end-to-end biological platform that complements its traditional strengths in synthetic crop protection chemistries.
The new strategic alliance creates a powerful foundation for FMC and Chr. Hansen to compete in the multi-billion dollar biological crop protection market. Under the arrangement, Chr. Hansen will provide scouting, screening, scale up, and fermentation manufacturing expertise while FMC will provide scouting, screening, formulation capabilities, product development and registration experience, and global market access. The two companies will develop new products, knowledge, and biological expertise within the collaboration’s framework. FMC and Chr. Hansen have been working together on select projects for several years and this alliance represents the culmination of what has already been a productive relationship.
FMC’s acquisition of CAEB gives the company a proprietary discovery and development platform through the addition of a research facility, a team of accomplished scientists, a pipeline of biological products in various stages of development, and a world-class library of microbes with deep intellectual property assets, including patent-pending technologies.
CAEB’s facility, located in Research Triangle Park, N.C., will become a biological center of excellence within FMC’s global research and development network. The work conducted at the facility will feed directly into FMC’s strategic alliance with Chr. Hansen.